Journals in Neurophysiology

5 results in All results

Clinical Neurophysiology

• ISSN: 1388-2457
• 5 Year impact factor: 3.9
• Impact factor: 3.7

Official Organ of the International Federation of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, and the International Society of Intraoperative Neurophysiology.SCOPE OF THE JOURNAL: Clinical Neurophysiology is dedicated to publishing scholarly reports on the pathophysiology underlying diseases of the peripheral and central nervous system of humans. Reports on clinical trials that use neurophysiological measures as endpoints are encouraged, as are manuscripts on integrated neuroimaging of peripheral and central nervous function including, but not limited to, functional MRI, brain mapping, MEG, EEG, PET, ultrasound, and other neuroimaging modalities. Studies on normal human neurophysiology are welcome, if they are relevant to disease or clinical applications. Studies on animals and technical reports must have clear applicability to human disease. Case reports may be considered (exclusively as Letters-to-the-Editor), if implying substantial advancement of knowledge.Clinical Neurophysiology covers epilepsy, developmental clinical neurophysiology, psychophysiology and psychopathology, motor control and movement disorders, somatosensory disorders including pain, motor neuron diseases, neuromuscular diseases, neuropathies, sleep and disorders of consciousness, auditory and vestibular disorders, aging, Alzheimer's disease, other dementias, other psychiatric disorders, autonomic disorders, neural plasticity and recovery, intraoperative and ICU monitoring, and therapeutic clinical neurophysiology including non-invasive and invasive brain stimulation.All studies published in Clinical Neurophysiology must stand on their own and make a substantial contribution to the literature. The journal does not afford a high priority to 'pilot' or 'preliminary' studies or to negative studies that do not advance knowledge.Reports with a focus on education or clinical practice, case reports, methodological and technical reports and studies reporting normative data on healthy subjects are preferentially being considered in Clinical Neurophysiology Practice, a companion journal of Clinical Neurophysiology.AUDIENCE:Neurologists, Clinical Neurophysiologists, Neuroscientists, Neuroimagers, Psychiatrists, Neuropsychologists, NeurosurgeonsSee also the BRAND NEW Companion Journal Clinical Neurophysiology Practice

Subscribe

Hearing Research

• ISSN: 0378-5955
• 5 Year impact factor: 2.9
• Impact factor: 2.5

The aim of the journal is to provide a forum for papers concerned with basic peripheral and central auditory mechanisms. Emphasis is on experimental and clinical studies, but theoretical and methodological papers will also be considered. The journal publishes original research papers, review and mini- review articles, rapid communications, method/protocol and perspective articles.Papers submitted should deal with auditory anatomy, physiology, psychophysics, imaging, modeling and behavioural studies in animals and humans, as well as hearing aids and cochlear implants. Papers dealing with the vestibular system are also considered for publication. Papers on comparative aspects of hearing and on effects of drugs and environmental contaminants on hearing function will also be considered. Clinical papers will be accepted when they contribute to the understanding of normal and pathological hearing functions.AUDIENCEAudiologists, Biologists, Otologists, Physiologists, Neurologists, Neuroscientists, Psychologists.

Subscribe

Neuromuscular Disorders

• ISSN: 0960-8966
• 5 Year impact factor: 3.2
• Impact factor: 2.7

Official Journal of the World Muscle SocietyThis international, multidisciplinary journal covers all aspects of neuromuscular disorders in childhood and adult life (including the muscular dystrophies, spinal muscular atrophies, hereditary neuropathies, congenital myopathies, myasthenias, myotonic syndromes, metabolic myopathies and inflammatory myopathies).The Editors welcome original articles from all areas of the field: • Clinical aspects, such as new clinical entities, case studies of interest, treatment, management and rehabilitation (including biomechanics, orthotic design and surgery). • Basic scientific studies of relevance to the clinical syndromes, including advances in the fields of molecular biology and genetics. • Studies of animal models relevant to the human diseases.The journal is aimed at a wide range of clinicians, pathologists, associated paramedical professionals and clinical and basic scientists with an interest in the study of neuromuscular disorders.In addition to original research papers, the journal also publishes reviews and mini-reviews, preliminary short communications and book reviews, and has editorial, correspondence and news sections. Reports on congresses and workshops, taking the form of a digested or very comprehensive commentary, pointing out some of the particular highlights in relation to the contributors and giving some detail of the area covered, important contributions and a list of participants, are also welcome.The journal is published monthly and aims at rapid publication of high quality papers of scientific merit as well as general interest to a wide readership. There is also a fast track for rapid publication of new material of outstanding scientific merit and importance.Neuromuscular Disorders is the official journal of the World Muscle Society an international, multidisciplinary, scientific society, dedicated to the advancement and dissemination of knowledge in the field of neuromuscular disorders.

Subscribe

Neuropharmacology

• ISSN: 0028-3908
• 5 Year impact factor: 4.5
• Impact factor: 4.6

Neuropharmacology publishes high quality, original research within the discipline of neuroscience. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. Work with non-mammalian and invertebrate species may be considered in exceptional circumstances. The journal does not usually accept clinical research, although neuropharmacological studies in humans may be considered on the condition that they provide novel insight into either the actions of drugs and/or neurobiological mechanisms. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Similarly, manuscripts describing the use of natural products will only be considered if the active ingredient is known and disclosed.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.Neuropharmacology also publishes topical narrative reviews on subjects within its remit. These reviews are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief of their intention to submit a review. Potential review authors should clearly indicate in the cover letter their expertise in the area, the timeliness of the topic, and how the review differs from, and adds to, recent published reviews on related topics. Authors are expected to have an established experimental track record in the topic of the review, and should provide full citations, including URLs/DOIs, of recent experimental papers in peer-reviewed journals relevant to the topic of the review in their cover letter. In the absence of an experimental track record, authors should provide a justification for why they believe they are the right persons to author this review article at this point in time. The absence of any such evidence of relevant experimental expertise or an explanation of author appropriateness will result in the return of the manuscript to the authors. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a prompt decision regarding the proposed review. Systematic reviews, meta- or bibliographic analyses will not be considered unless they are a necessary part of a Special Issue and conducted by experts in the field, and even then only under exceptional circumstances and at the discretion of the Editor-in-Chief.

Subscribe

Parkinsonism & Related Disorders

• ISSN: 1353-8020
• 5 Year impact factor: 3.8
• Impact factor: 3.1

Official Journal of the International Association of Parkinsonism and Related Disorders Parkinsonism & Related Disorders is a companion journal to Clinical Parkinsonism & Related DisordersParkinsonism & Related Disorders publishes the results of translational and clinical research contributing to the understanding, diagnosis and treatment of movement disorders and all neurodegenerative syndromes in which parkinsonism, essential tremor or related movement disorders may be a feature. Parkinsonism & Related Disorders welcomes reviews, points of views, original articles, short communications, interesting cases for movement disorder rounds and correspondences to the editor.Topics covered will include: • Molecular biology • Neuroanatomy • Neurophysiology/electrophysiology • Neuropharmacology • Neuropsychology • Neuroimaging • Neurotoxicology • Clinical phenomenology • Surgical and pharmacological treatment • Transplantation studies • Relationship with aging • Epidemiology/environmental impact factors • RehabilitationThe journal will form a truly international channel of communication between the research and clinical communities.Manuscripts with a primary focus on clinical aspects of movement disorders should be submitted to Clinical Parkinsonism & Related Disorders .

Subscribe